Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive …
RH Perlis, AA Nierenberg, JE Alpert… - Journal of Clinical …, 2002 - journals.lww.com
Patients with major depressive disorder remain at risk for relapse following remission and
often continue to experience subthreshold symptoms. This study compared the rate of …
often continue to experience subthreshold symptoms. This study compared the rate of …
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive …
RH Perlis, AA Nierenberg, JE Alpert… - Journal of Clinical …, 2002 - einstein.elsevierpure.com
Patients with major depressive disorder remain at risk for relapse following remission and
often continue to experience subthreshold symptoms. This study compared the rate of …
often continue to experience subthreshold symptoms. This study compared the rate of …
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive …
RH Perlis, AA Nierenberg, JE Alpert… - Journal of clinical …, 2002 - pubmed.ncbi.nlm.nih.gov
Patients with major depressive disorder remain at risk for relapse following remission and
often continue to experience subthreshold symptoms. This study compared the rate of …
often continue to experience subthreshold symptoms. This study compared the rate of …
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive …
RH Perlis, AA Nierenberg, JE Alpert, J Pava… - Journal of Clinical …, 2002 - europepmc.org
Patients with major depressive disorder remain at risk for relapse following remission and
often continue to experience subthreshold symptoms. This study compared the rate of …
often continue to experience subthreshold symptoms. This study compared the rate of …
[引用][C] Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major …
RH PERLIS, AA NIERENBERG… - Journal of clinical …, 2002 - pascal-francis.inist.fr
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual
depressive symptoms in continuation treatment of major depressive disorder CNRS Inist …
depressive symptoms in continuation treatment of major depressive disorder CNRS Inist …
The effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive …
RH Perlis, AA Nierenberg, JE Alpert… - Journal of Clinical …, 2002 - psycnet.apa.org
This study compared the rate of relapse of major depressive disorder and the prevalence of
residual depressive symptoms during the continuation phase for patients treated with …
residual depressive symptoms during the continuation phase for patients treated with …